There were two companies in cities associated with Montgomery County, Maryland, that received two FDA inspections in the first quarter of 2025, according to reports from the U.S. Food and Drug Administration (FDA).
This is a 66.7% decrease from the number of companies inspected in the previous quarter, when six companies received six inspections.
The companies inspected were involved in the Biologics sector.
Both of the companies were in line with FDA regulations, and don’t need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| NIH Clinical Center | Biologics | 01/21/2025 | No Action Indicated (NAI) |
| NIH Donor Center at Fishers Lane | Biologics | 03/06/2025 | No Action Indicated (NAI) |
